Penfund invests $47 mln in OMERS' buy of Forefront Dermatology

Canadian private equity firm Penfund has invested US$47 million of second lien debt and equity in Forefront Dermatology, a provider of practice management services to dermatology clinics. The investment was made in support of OMERS Private Equity's previously announced acquisition of the Manitowoc, Wis.-based company from Varsity Healthcare Partners. Toronto-based Penfund, a provider of junior capital to mid-market companies in the United States and Canada, has partnered with OMERS in the past. In late 2013, Penfund extended a loan to Caliber Collision Centers Inc shortly after its acquisition by OMERS.

17 February 2016•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles